Opioids and respiratory depression

Respiratory Care

Volumn 44, Issue 1, 1999, Pages 78-80

  Davis, Thomas A ^a   Mathewson, Hugh S ^a,b  

^a Nurse Anesthesia Education ^*  (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALFENTANIL; BUPRENORPHINE; BUTORPHANOL; CLONIDINE; CODEINE; DEZOCINE; FENTANYL; KETOROLAC; MORPHINE; NALBUPHINE; NALMEFENE; NALOXONE; NALTREXONE; NARCOTIC AGENT; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE RECEPTOR; PARACETAMOL; PENTAZOCINE; PETHIDINE; REMIFENTANIL; SUFENTANIL;

ARTICLE; CHRONIC PAIN; DRUG INDUCED DISEASE; EPIDURAL DRUG ADMINISTRATION; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; POSTOPERATIVE PAIN; RESPIRATION DEPRESSION; RESPIRATORY FAILURE; RISK ASSESSMENT;

EID: 0033038479     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Marks RM, Sachar EJ. Undertreatment of medical inpatients with narcotic analgesics. Ann Int Med 1973;78(12):173-181.
2. Weissman DE, Doctors, opioids, and the law: the effect of controlled substances regulations on cancer pain management (review) Semin Oncol 1993;20(2 Suppl 1):53-58.
3. Bernabei R, Gambassi G, Lapane K, Landi F, Gatsonis C, Dunlop R, et al. Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA 1998;279 (23): 1877-1882.
4. Letter to all 50 state medical boards from the Compassion in Dying Federation, Portland, Oregon, Jan 12, 1998.
5. Mulroy MF. Monitoring opioids (review). Reg Anesth 1996:21(6 Suppl):89-93.
6. Pasero CL, McCaffery M. Avoiding opioid-induced respiratory depression. Am J Nurs 1994;94(4):24-30.
7. Sinatra RS. Current methods of controlling post-operative pain (review). Yale J Biol Med 1991;64(4):351-374.
8. Chaney MA. Side effects of intrathecal and epidural opioids (review). Can J Anaesth 1995:42(10):891-903.
9. Bruelle P, Ferrer JM, Macheboeuf M, Roert C, Viel E, Eledjam JJ. [The use of opioids by the regional route in obstetrics.] Cah Anesthesiol 1991;39(2):97-103
10. Egbert AM Postoperative pain management in the frail elderly (review) Clin Geriatr Med 1996;12(3):583-599.
11. Bailey PL, Clark NJ, Pace NL, Stanley TH, East KA. van Vreeswijk H, et al. Antagonism of postoperative opioid-induced respiratory depression: nalbuphine versus naloxone. Anesth Analg 1987,66(11): 1109-1114.
12. Jarvis DA, Duncan SR, Segal IS, Maze M, Ventilatory effects of clonidine alone and in the presence of alfentanil. in human volunteers. Anesthesiology 1992;76(6):899-905.
13. Atcheson R, Lambert DG. Update on opioid receptors (editorial) Br J Anaesth 1994;73(2):132-134.
14. Freye E, Latasch L, Portoghese PS. The delta receptor is involved in sufentanil-induced respiratory depression-opioid subreceptors mediate different effects. Eur J Anaesthesiol 1992;9(6):457-462
15. Freye E, Schnitzler M, Schenk G. Opioid-induced respiratory depression and analgesia may be mediated by different subreceptors. Pharm Res 1991;8(2):196-199.
16. Willette RN, Doorley BM, Sapru HN. Activation of cholinergic mechanisms in the medulla oblongata reverse intravenous opioidinduced respiratory depression J Pharmacol Exp Ther 1987:240(1): 352-358.
17. Borgbjerg FM, Nielsen K, Franks J Experimental pain stimulates respiration and attenuates morphine-induced respiratory depression a controlled study in human volunteers. Pain 1996,64(1):123-128
18. Watson WA, Steele MT, Muelleman RL, Rush MD. Opioid toxicity recurrence after an initial response to naloxone. J Toxicol Clin Toxicol 1998;36(1-2):11-17.
19. Diehl DL. Acupuncture's transition to credibility in the United States: the latest chapter. J Altern Complement Med 1997;3(4):421-423.